Results of a Multicenter Open-Label Randomized Trial Evaluating Infusion Duration of Zoledronic Acid in Multiple Myeloma Patients (the ZMAX Trial)James R. Berenson, Robert C. Collins, Timothy Lopez et al.|The Journal of Supportive Oncology|2011Cited by 10